Santen Pharmaceutical Co (JP:4536) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Santen Pharmaceutical Co. has successfully repurchased over 2.2 million of its common shares, amounting to nearly 3.94 billion yen, as part of its ongoing share buyback program. This strategic move aligns with their broader plan to repurchase up to 21.11 million shares by November 6, 2024, reflecting a commitment to enhancing shareholder value.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue